SEARCH

SEARCH BY CITATION

References

  • Allen, A., Flemstrom, G. (2005) Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am. J. Physiol. Cell Physiol. 288: C1C19.
  • Amieva, M. R., Vogelmann, R., Covacci, A., Tompkins, L. S., Nelson, W. J., Falkow, S. (2003) Disruption of the epithelial-junctional complex by Helicobacter pylori CagA. Science 300: 14301434.
  • Anderson, J. M., Van Itallie, C. M. (1995) Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269: G467G475.
  • Angelova, M. J., Soleau, S. Melaeard, P., Faucon, J. F. Bothorel, P. (1992) Preparation of giant vesicles by AC electric fields. Progr. Colloid Polym. Sci. 89: 127131.
  • Atuma, C., Strugala, V., Allen, A., Holm, L. (2001) The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G922G929.
  • Barreto, J., Lichtenberger, L. M. (1992) Vesicle acidification driven by a millionfold proton gradient: a model for acid influx through gastric cell membranes. Am. J. Physiol. Gastrointest. Liver Physiol. 25: G30G34.
  • Bombardier, C., Laine, L., Reich, A. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N. Engl. J. Med. 343: 15201528.
  • Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Ridell, R., Morton, D., Lanas, A., Konsta, M. A., Baron, J. A. (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial (APPROVe). N. Engl. J. Med. 352: 10921102.
  • Cantor, R. S. (1999) Lipid composition and the lateral pressure profile in bilayers. Biophys. J. 76: 26252639.
  • Cevc, G., Marsh, D. (1987) Phospholipid bilayers: physical principles and models. In: Bittar, E. E. (ed.) Cell biology: a series of monographs. John Wiley & Sons Inc., New York, NY, p. 422.
  • Darling, R. L., Romero, J. J., Dial, E. J., Akunda, J. K., Langenbach, R., Lichtenberger, L. M. (2004) The effects of aspirin on gastric mucosal integrity, surface hydrophobicity and prostaglandin metabolism in COX knockout mice. Gastroenterology 127: 94104.
  • Davenport, H. W. (1964) Gastric mucosal injury by fatty and acetyl salicylic acid. Gastroenterology 46: 245253.
  • Davenport, H. W. (1965) Damage to the gastric mucosa: effects of salicylates and stimulation. Gastroenterology 49: 189195.
  • Davenport, H. W. (1972) Why the stomach does not digest itself. Sci. Am. 226: 8693.
  • Dial, E. J., Dohrman, A. J., Romero, J. J., Lichtenberger, L. M. (2004) Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents. J. Pharm. Pharmacol. 57: 9399.
  • Emery, P., Zeidler, H., Kvien, T. K. Guslandi, M., Naudin, R., Stead, H., Verburg, K. M., Isakson, P. C., Hubbard, R. C., Geis, R. S. (1999) Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomized double blind comparison. Lancet 354: 21062111.
  • Evans, E., Rawicz, W. (1990) Entropy-driven tension and bending elasticity in condensed-fluid membranes. Phys. Rev. Lett. 64: 20942097.
  • Evans, E. A., Waugh, R., Melnik, L. (1976) Elastic area compressibility modulus of red cell membrane. Biophys. J. 16: 585595.
  • Evans, E., Heinrich, V. Ludwig, F., Rawicz, W. (2003) Dynamic tension spectroscopy and strength of biomembranes. Biophys. J. 85: 23422350.
  • Fasano, A. (2000) Regulation of intercellular tight junctions by zona occludins toxin and its eukaryotic analogue zonulin. Ann. NY Acad. Sci. 915: 214222.
  • Ferreira, H., Lucio, M., Lima, J. L. F. C., Cordeiro-da-Silva, Tavares, J., Reis, S. (2005a) Effect of anti-inflammatory drugs on splenocyte membrane fluidity. Anal. Biochem. 339: 144149.
  • Ferreira, H., Lucio, M., Lima, J. L. F. C., Matos, C. J., Reis, S. (2005b) Effects of diclofenac on EPC liposome membrane properties. Anal. Bioanal. Chem. 382: 12561264.
  • Giraud, M.-N., Motta, C., Romero, J. J., Bommelaer, G., Lichtenberger, L. M. (1999) Interaction of indomethacin and naproxen with gastric surface-active phospholipids: a possible mechanism for the gastric toxicity of NSAIDs. Biochem. Pharmacol. 57: 247254.
  • Goddard, P. J., Lichtenberger, L. M. (1987) Does aspirin damage the canine gastric mucosa by reducing its surface hydrophobicity Am. J. Physiol. Gastrointest. Liver Physiol. 15: G421G430.
  • Goddard, P. J., Kao Y.-C. J., Lichtenberger, L. M. (1990) Luminal surface hydrophobicity of canine gastric mucosa is dependent on a surface mucous gel. Gastroenterology 98: 361370.
  • Hills, B. A., Butler, B. D., Lichtenberger, L. M. (1983) Gastric mucosal barrier: the hydrophobic lining to the lumen of the stomach. Am. J. Physiol. Gastrointest. Liver Physiol. 7: G561G568.
  • Hippisley-Cox, J., Coupland, C., Logan, R. (2005) Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. Br. Med. J. 331: 13101316.
  • Isenberg, J. I., Selling, J. A., Hogan, D. L., Koss, M. A. (1987) Impaired proximal duodenal mucosal bicarbonate secretion in duodenal ulcer patients. N. Engl. J. Med. 316: 374379.
  • Israelachvili, J. N., Marcelja, S., Horn, R. G. (1980) Physical principles of membrane organization. Q. Rev. Biophys. 13: 121200.
  • Ito, S., Lacy, E. R. (1985) Morphology of rat gastric mucosal damage, defense and restitution in the presence of luminal ethanol. Gastroenterology 88: 250260.
  • Juni, P., Rutjes, J. P., Dieppe, P. A. (2002) Are selective COX-2 inhibitors superior to traditional non steroidal anti-inflammatory drugs Br. Med. J. 324: 12871288.
  • Konturek, P. C., Konturek, S. J., Hahn, E. J. (2004) Duodenal alkaline secretion: its mechanisms and role in mucosal protection against acid. Dig. Liv. Dis. 36: 505512.
  • Lacy, E. R. (1988) Epithelial restitution in the gastrointestinal tract. J. Clin. Gastroenterol. 10 (Suppl.): S72S77.
  • Laine, L., Harper, S., Simon, T., Bath, R., Johanson, J., Schwartz, H., Stern, S., Quan, H., Bolognese, J. (1999) A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology 117: 776783.
  • Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A. Goulding, E. H., Kluckman, K. D., Smithies, O. (1995) Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83: 483492.
  • Lichtenberger, L. M. (1995) The hydrophobic barrier properties of gastrointestinal mucus. Annu. Rev. Physiol. 57: 565583.
  • Lichtenberger, L. M. (1999) Gastroduodenal mucosal defense. Curr. Opin. Gastroenterol. 15: 463472.
  • Lichtenberger, L. M. (2001) Where is the evidence the cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem. Pharmacol. 61: 631637.
  • Lichtenberger, L. M., Wang Z.-M., Romero, J. J., Ulloa, C., Perez, J. C., Giraud, M.-N., Barreto, J. C. (1995) Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat. Med. 1: 154158.
  • Ligumsky, M., Grossman, M. I., Kauffman, G. L. (1982) Endogenous gastric mucosal prostaglandins: their role in mucosal integrity. Am. J. Physiol. 242: G337G341.
  • Ligumsky, M., Golanska, E. M., Hansen, D. G., Kauffman, G. L. (1983) Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in the rat. Gastroenterology 84: 756761.
  • Ligumsky, M., Sestieri, M., Karmeli, F., Zimmerman, J., Okon, E., Rachmilewitz, D. (1990) Rectal administration of nonsteroidal antiinflammatory drugs. Gastroenterology 98: 12451249.
  • Ly, H. V., Longo, M. L. (2004) The influence of short-chain alcohols on interfacial tension, mechanical properties, area/molecule, and permeability of fluid lipid bilayers. Biophys. J. 87: 10131033.
  • Ma, T. Y., Nguyen, D., Bui, V., Nguyen, H., Hoa, N. (1999) Ethanol modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. 276: G965G974.
  • Masferrer, J. L., Zioeifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., Seibert, K. (1994) Selective inhibition of inducible cyclo-oxygenase-2 in vivo is anti-inflammatory and non-ulcerogenic. Proc. Natl Acad. Sci. 91: 32283232.
  • McCormack, K., Brune, K. (1987) Classical absorption theory and the development of gastric mucosal damage associated with non-steroidal anti-inflammatory drugs. Arch. Toxicol. 60: 261269.
  • Mitchell, J. A., Akarasreenont, P., Thiemermann, C., Flower, R. J., Vane, J. R. (1993) Selectivity of NSAIDs as inhibitors of constitutive and inducible cyclo-oxygenase. Proc. Natl Acad. Sci. 90: 1169311697.
  • Mukherjee, D., Nissen, S. E., Topol, E. J. (2001) Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286: 954959.
  • Nussmeier, N. A., Whelton, A. A., Brown, M. T., Langford, R. M., Hoeft, A., Parlow, J. L., Boyce, S. W., Verburg, K. M. (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N. Engl. J. Med. 352: 10811091.
  • Podolsky, D. K. (2000) Mechanisms of regulatory peptide action in the gastrointestinal tract. J. Gastroenterol. 35 (Suppl. 1): 6974.
  • Raphael, R. M., Popel, A. S., Brownell, W. E. (2000) A membrane bending model of outer hair cell electromotility. Biophys. J. 78: 28442862.
  • Rawicz, W., Olbrich, K. C., McIntosh, T., Needham, D., Evans, E. (2000) Effect of chain length and unsaturation on elasticity of lipid bilayers. Biophys. J. 79: 328339.
  • Robert, A., Nezamis, J. E., Lancaster, C., Hanchar, A. J. (1979) Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 70: 359370.
  • Sanders, M. J., Ayalon, A., Roll, M., Soll, A. H. (1985) The apical surface of canine chief cell monolayers resist H+ back-diffusion. Science 313: 5254.
  • Silverstein F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. W. M., Stenson, W. F., Burr, A. R. M., Zhao, W. W., Kent, J. D., Lefkowith, J. B., Verburg, K. M., Geis, G. S. (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284: 12471255.
  • Soloman, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., Bertagnolli, M. (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 352: 10711081.
  • Takahashi, M., Takada, H., Takagi, K., Kataoka, S., Soma, R., Kuwayama, H. (2003) Gastric restitution is inhibited by dexamethasone, which is reversed by hepatocyte growth factor and rebamipide. Aliment. Pharmacol. Ther. 18 (Suppl. 1): 126132.
  • Tomisato, W., Tanaka, K., Katsu, T., Kakuta, H., Sasaki, K., Tsutsumi, S., Hoshino, T., Aburaya, M., Li, D., Tsuchiya, T., Suzuki, K., Yokomizo, K., Mizushima, T. (2004) Membrane per-meabilization by non-steroidal anti-inflammatory drugs. Biochem. Biophys. Res. Commun. 323: 10321039.
  • Turner, J. R., Rill, B. K., Carlson, S. L., Carnes, D., Kerner, R., Morsny, R. J., Madara, J. L. (1997) Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273: C13781385.
  • Vane, J. R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature 231: 232251.
  • Vane, J. R., Botting, R. M. (1998) Mechanism of action of nonsteroidal anti-inflammatory drugs. Am. J. Med. 104: 2S8S.
  • Wallace, J. L. (1997) Nonsteroidal anti-inflammatory drugs and gastropathy: the second hundred years. Gastroenterology 112: 10001016.
  • Wallace, J. L., McKnight, W., Reuter, B. K., Vergnolle, N. (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119: 706714.
  • Whittle, B. J. R. (1981) Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80: 9498.
  • Whittle, B. J. R., Higgs, G. A., Eakins, K. E., Moncada, S., Vane, J. R. (1980) Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284: 271273.
  • Zhelev, D. V. (1998) Material property characteristics for lipid bilayers containing lysolipid. Biophys. J. 75: 321330.
  • Zhou, Y., Raphael, R. M. (2005) Effect of salicylate on the elasticity, bending stiffness, and strength of SOPC membranes. Biophys. J. 89: 17891801.